Mexico grants approval for Merck's antiviral covid treatment

Mexico's health regulator has granted authorization for emergency use of drugmaker Merck's (MRK.N) COVID-19 pill Molnupiravir, President Andres Manuel Lopez Obrador said on Friday.

The health regulator, COFEPRIS, was expected to soon also approve Pfizer's (PFE.N) Paxlovid pill to treat COVID-19, Lopez Obrador added at a regular news conference. Both medications were approved last month in the United States.

Molnupiravir was developed with Ridgeback Biotherapeutics and shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness.

Lopez Obrador said he planned to make both medications available in public hospitals.

Now your pharma company can procure Covid Antivirals and Vaccines: ALLVAXX